For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising ...

Using CRISPR co-culture screens, researchers found that deleting CHD1 and MAP3K7 makes tumor cells more vulnerable to immune ...

Join the ELRIG conference to hear from experts on cell and gene therapy. Discover advancements shaping the future of medicine.

New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.

A new publication from CorriXR Therapeutics, an oncology focused biotherapeutics company developing genetic medicines to ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

Genome Editing Market Genome Editing Market Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Global ...

The "Mice Model Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Mice Model ...

In Argentina, equine cloning in polo is no longer a rarity. It’s now a mature industry — although ethical dilemmas ...

Advancements in genome editing technologies the growing emphasis on safe and accurate gene correction, and strong biotechnology R&D investment drive the base editing market.Austin, Texas, Jan. 21, ...

Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological malignancies, today announced that it has received ...